Cargando…
Research Progress on Catalpol as Treatment for Atherosclerosis
Coronary atherosclerotic heart disease, cerebrovascular disease, and peripheral artery disease are common diseases with high morbidity and mortality rates and must be addressed. Their most frequent complications, including myocardial infarction and stroke, are caused by spontaneous thrombotic occlus...
Autores principales: | He, Lei, Zhao, Rusheng, Wang, Youheng, Liu, Huibing, Wang, Xuehui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313760/ https://www.ncbi.nlm.nih.gov/pubmed/34326774 http://dx.doi.org/10.3389/fphar.2021.716125 |
Ejemplares similares
-
Activation of the sirtuin silent information regulator 1 pathway inhibits pathological myocardial remodeling
por: Wang, Youheng, et al.
Publicado: (2023) -
Catalpol Inhibits Macrophage Polarization and Prevents Postmenopausal Atherosclerosis Through Regulating Estrogen Receptor Alpha
por: Chen, Qi, et al.
Publicado: (2021) -
Effect and Mechanism of Catalpol on Remyelination via Regulation of the NOTCH1 Signaling Pathway
por: Sun, Yaqin, et al.
Publicado: (2021) -
Catalpol Ameliorates Podocyte Injury by Stabilizing Cytoskeleton and Enhancing Autophagy in Diabetic Nephropathy
por: Chen, Yan, et al.
Publicado: (2019) -
Catalpol ameliorates CFA-induced inflammatory pain by targeting spinal cord and peripheral inflammation
por: Zhao, Baoxia, et al.
Publicado: (2022)